Pooja Hegde
Eli Lilly (United States)(US)University of Minnesota Medical Center(US)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Biochemical and Molecular Research, Cancer therapeutics and mechanisms, Antibiotic Resistance in Bacteria
Most-Cited Works
- → MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections(2018)45 cited
- → Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection(2019)33 cited
- → Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors(2022)24 cited
- → Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance(2022)20 cited
- → β-Lactamase-Mediated Fragmentation: Historical Perspectives and Recent Advances in Diagnostics, Imaging, and Antibacterial Design(2022)16 cited
- → Formulation and characterization of ternary amorphous solid dispersions of a highly potent anti-tubercular agent and curcumin(2021)15 cited
- → Reinvestigation of the structure-activity relationships of isoniazid(2021)15 cited
- → 8-cyanobenzothiazinone analogs with potent antitubercular activity(2021)14 cited
- → Structural Determinants of Indole-2-carboxamides: Identification of Lead Acetamides with Pan Antimycobacterial Activity(2022)14 cited
- → Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS)(2022)13 cited